A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial

OBJECTIVE: The role of U300 glargine insulin for the inpatient management of type 2 diabetes (T2D) has not been determined. We compared the safety and efficacy of glargine U300 versus glargine U100 in noncritically ill patients with T2D. RESEARCH DESIGN AND METHODS: This prospective, open-label, ran...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Diabetes Care
Main Authors: Pasquel, Francisco J., Lansang, M. Cecilia, Khowaja, Ameer, Urrutia, M. Agustina, Cardona, Saumeth, Albury, Bonnie, Galindo, Rodolfo J., Fayfman, Maya, Davis, Georgia, Migdal, Alexandra, Vellanki, Priyathama, Peng, Limin, Umpierrez, Guillermo E.
Formato: Artigo
Idioma:Inglês
Publicado: American Diabetes Association 2020
Assuntos:
Emerging Therapies: Drugs and Regimens
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411278/
https://ncbi.nlm.nih.gov/pubmed/32273271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1940
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares